Back
Protagonist Therapeutics Vs. Impinj Industry Stock Comparison
Buy
56
PTGX
Protagonist Therapeutics
Last Price:
26.07
Seasonality Move:
28.29%
Sell
49
PI
Impinj
Last Price:
163.30
Seasonality Move:
27.55%
Buy
56
Protagonist Therapeutics (PTGX)
is a Buy
Is Protagonist Therapeutics a Buy, Sell or Hold?
- The current Protagonist Therapeutics [PTGX] share price is $26.06. The Score for PTGX is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
- PTGX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
49
Impinj (PI)
is a Sell
Is Impinj a Buy, Sell or Hold?
- The current Impinj [PI] share price is $163.33. The Score for PI is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
- PI is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PTGX Stock Price Chart
What is Protagonist Therapeutics's stock price today?
-
The Protagonist Therapeutics share price today is $26.06
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PTGX is experiencing slight buying pressure.
PTGX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.6 | Sell |
| Relative Strength Index (14 RSI): | 46.52 | Sell |
| Chaikin Money Flow: | 50618 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (25.34 - 27.74) | Sell |
| Bollinger Bands (100): | (23.57 - 29.09) | Sell |
PI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 11.07 | Buy |
| Relative Strength Index (14 RSI): | 72.51 | Buy |
| Chaikin Money Flow: | 289795 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
PTGX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 25.46 | Buy |
| 20-day SMA: | 26.18 | Sell |
| 50-day SMA: | 28.05 | Sell |
| 200-day SMA: | 21.96 | Buy |
| 8-day EMA: | 25.77 | Buy |
| 20-day EMA: | 26.22 | Sell |
| 50-day EMA: | 26.76 | Sell |
| 200-day EMA: | 23.63 | Buy |
PI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 157.74 | Buy |
| 20-day SMA: | 135.9 | Buy |
| 50-day SMA: | 125.62 | Buy |
| 200-day SMA: | 87.57 | Buy |
| 8-day EMA: | 154.29 | Buy |
| 20-day EMA: | 141.72 | Buy |
| 50-day EMA: | 127.59 | Buy |
| 200-day EMA: | 102.38 | Buy |
Protagonist Therapeutics Earnings Growth & PTGX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.87 per share, and a decrease next year of $0.23 per share.
Impinj Earnings Growth & PI Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.50 per share, an increase next quarter of $0.47 per share, an increase this year of $1.10 per share, and an increase next year of $0.65 per share.
Protagonist Therapeutics Technical Analysis
| Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Impinj Technical Analysis
| Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||